Unlocking AI’s Potential in Pharma

The transformative impact of Artificial Intelligence (AI) on life sciences is indisputable. Join us on an exploration of AI’s potential within the pharmaceutical and healthcare industry. Hear two thought leaders discuss AI as a catalyst to create a more efficient and accessible healthcare future.

The transformative impact of Artificial Intelligence (AI) on life sciences is indisputable. Join us on an exploration of AI’s potential within the pharmaceutical and healthcare industry. Hear two thought leaders discuss AI as a catalyst to create a more efficient and accessible healthcare future

Speakers

Chris Mansi, MD

Chief Executive Officer, Viz.ai

Chris Mansi, MD is CEO and Co-Founder of Viz.ai, the leader in AI-powered disease detection and care coordination.  Dr. Mansi co-founded Viz.ai in 2016 with a mission of using artificial intelligence to increase access to life-saving treatments.

Greg Meyers

Executive Vice President, Chief Digital & Technology Officer, Bristol Myers Squibb

As executive vice president and chief digital and technology officer of Bristol Myers Squibb (BMS), Greg Meyers leads the company’s efforts to coalesce digital technology alongside the company's transformational science to get more medicines, to more patients, faster and more impactfully.

For more, please find the original story source here.